Patents
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
02/2003
02/06/2003WO2003010199A2 Identification of specific tumour antigens by means of the selection of cdna libraries with sera and the use of said antigens in diagnostic imaging techniques
02/06/2003WO2003010198A1 Identification of specific tumour antigens by selection of cdna libraries with sera and use of said antigens in diagnostic techniques
02/06/2003WO2003010196A2 Variants and exons of the glyt1 transporter
02/06/2003WO2003009817A2 Stable lyophilized pharmaceutical formulation of igg antibodies
02/06/2003WO2003009815A2 Compositions and methods for modulating blood-brain barrier transport
02/06/2003WO2003009808A2 Methods, compositions and kits relating to chitinases and chitinase-like molecules and inflammatory disease
02/06/2003WO2003009803A2 Method of improving cognitive function
02/06/2003WO2003009740A2 Methods for treating or preventing sclerotic disorders using cd2-binding agents
02/06/2003WO2002095034A3 A retinoic acid metabolizing cytochrome p450
02/06/2003WO2002063005A3 Lipid-associated molecules
02/06/2003WO2002061389A3 Methods to generate and identify monoclonal antibodies to a large number of human antigens
02/06/2003WO2002060950A3 Flt4(vegfr-3) as a target for tumor imaging and anti-tumor therapy
02/06/2003WO2002040545A9 Reduction of the nonspecific animal toxicity of immunotoxins by mutating the framework regions of the fv to lower the isoelectric point
02/06/2003WO2002032925A9 Protein scaffolds for antibody mimics and other binding proteins
02/06/2003WO2002028904A3 Human anti-cd40 antibodies
02/06/2003WO2002021996A3 Methods of diagnosis of colorectal cancer, compositions and methods of screening for colorectal cancer modulators
02/06/2003WO2002020722A3 Methods and compositions for in vitro targeting
02/06/2003WO2002016602A3 Compositions and methods for the diagnosis and treatment of tumor
02/06/2003WO2002014470A3 Expression of herstatin, an alternative her-2/neu product, in cells that express either p185her-2 or the egf receptor inhibits receptor activity and cell growth
02/06/2003WO2002012528A3 Enhanced 2-keto-l-gulonic acid production
02/06/2003WO2002010217A9 Endothelial cell expression patterns
02/06/2003WO2001066139A9 Use of a compound that selectively binds to cd123 to impair hematologic cancer progenitor cell
02/06/2003WO2001064717A9 Novel therapeutic treatment of chronic obstructive pulmonary disease
02/06/2003WO2001048214A8 METHOD FOR PRODUCING 6-0-α-D-GLUCOPYRANOSYL-D-SORBITE
02/06/2003US20030028923 Nucleotide sequences coding enzymatic polypeptide for use in the generation of disease resistant plants
02/06/2003US20030028913 Generation of antibody with preferential binding activity; obtain plant, transform with nucleotide sequences coding immunoglobulin, express nucleotide sequences, recover imunoglobulin
02/06/2003US20030028905 Mutant forms of the TGF-beta type II receptor which bind all TGF-beta isoforms
02/06/2003US20030028009 Polypeptide for use in the treatment of arthritis, psoriasis, cancer, inflammation, and diabetic retinopathy
02/06/2003US20030028008 Nucleotide sequences coding polypeptide for use in the treatment of urogenital, tumor, antherosclerotic and kidney disorders
02/06/2003US20030028006 Cytokine receptor common gamma chain like
02/06/2003US20030027999 143 human secreted proteins
02/06/2003US20030027994 Humanized antibody or antibody fragment for use in the diagnosis and treatment of cancer
02/06/2003US20030027993 Secreted and transmembrane polypeptides and nucleic acids encoding the same
02/06/2003US20030027992 Secreted and transmembrane polypeptides and nucleic acids encoding the same
02/06/2003US20030027986 Secreted and transmembrane polypeptides and nucleic acids encoding the same
02/06/2003US20030027985 Secreted and transmembrane polypeptides and nucleic acids encoding the same
02/06/2003US20030027983 Transport protein for use in the treatment of blood, hypertensive and epileptic disorders
02/06/2003US20030027981 Urokinase-type plasminogen activator receptor
02/06/2003US20030027782 Method for treating allergic lung disease
02/06/2003US20030027776 For detecting, therapy, prophylaxis and/or prognosing disorders related to the tissues where these cancer antigens are expressed
02/06/2003US20030027774 For diagnosis and therapy of tuberculosis
02/06/2003US20030027759 Method of using PON-1 to decrease atheroma formation
02/06/2003US20030027754 As pharmaceuticals, diagnostics, biosensors and bioreactors
02/06/2003US20030027749 For use in therapy, and diagnostic assays
02/06/2003US20030027746 Useful in the development of human therapeutics and diagnostic formulations
02/06/2003US20030027744 Use of a CD40:CD154 binding interruptor to treat immunological complications of the eye
02/06/2003US20030027358 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (LIR)
02/06/2003US20030027319 Artificial antibody polypeptides
02/06/2003US20030027304 Compositions and methods for the treatment and prevention of cardiovascular diseases and disorders, and for identifying agents therapeutic therefor
02/06/2003US20030027297 19 human secreted proteins
02/06/2003US20030027284 Tumor necrosis factor-gamma
02/06/2003US20030027283 Protein l and hybrid proteins thereof
02/06/2003US20030027281 Secreted and transmembrane polypeptides and nucleic acids encoding the same
02/06/2003US20030027261 Novel genes TZap7/A, TZap7/B and TZap7 involved in T cell activation and uses thereof
02/06/2003US20030027256 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of tumors
02/06/2003US20030027254 Nucleotide sequences coding protein for use in the treatment of alzheimer's disease
02/06/2003US20030027253 Nucleotides equences codin polypeptide for use in the treatment of cancer
02/06/2003US20030027248 Human cDNAs and proteins and uses thereof
02/06/2003US20030027247 Antigen binding unit for use in human diagnostics and therapeutics
02/06/2003US20030027226 Monoclonal antibody for NKX3.1 and method for detecting same
02/06/2003US20030027213 Haploid yeast cells transformed with a library of expression vectors encoding a fully human antibody repertoire
02/06/2003US20030027212 Antibody for use in tissue classification
02/06/2003US20030027207 Anti-platelet binding proteins and polymer conjugates containing the same
02/06/2003US20030027198 Nucleotide sequences coding polypeptide for use in the treatment of tumors
02/06/2003US20030027194 Modular assembly of nucleic acid-protein fusion multimers
02/06/2003US20030027188 SLC7s as modifiers of the p53 pathway and methods of use
02/06/2003US20030027178 Methods and kits for determining a cancer diagnosis and prognosis
02/06/2003US20030027177 Human DNA mismatch repair proteins
02/06/2003US20030027164 Novel human nucleic acid molecules and polypeptides encoding a novel human ion channel expressed in spinal cord and brain
02/06/2003US20030027163 Secreted and transmembrane polypeptides and nucleic acids encoding the same
02/06/2003US20030027162 Secreted and transmembrane polypeptides and nucleic acids encoding the same
02/06/2003US20030027161 Human cDNAs and proteins and uses thereof
02/06/2003US20030027158 Novel nucleic acid sequences encoding human breast tumor-associated protein 47-like polypeptides
02/06/2003US20030027156 Generation of preferential proein; obtain nucleotide sequences, incubate with cells, transform cells, express nucleotide sequences, recover proteins
02/06/2003US20030027146 Nucleotide sequences coding polypeptide for use in the treatment of cancer and skin disorders
02/06/2003US20030027145 Nucleotide sequences coding polypeptide for use in the treatment of cancer and skin disorders
02/06/2003US20030027143 Secreted and transmembrane polypeptides and nucleic acids encoding the same
02/06/2003US20030026806 Complexing; antiinflammatory agents, rheumatic diseases
02/06/2003US20030026805 Genetic engineering; monoclonal antibody grafted to tumor necrosis factor
02/06/2003US20030026804 Combination therapies for B-cell lymphomas comprising administration of anti-CD20 antibody
02/06/2003US20030026803 Compositions for inhibiting macrophage activity
02/06/2003US20030026802 Interference with binding chemokines
02/06/2003US20030026801 Methods for enhancing antibody-induced cell lysis and treating cancer
02/06/2003US20030026800 Monoclonal antibodies, antigens and diagnosis and therapy of malignant diseases
02/06/2003US20030026799 Compositions and methods for the treatment and prevention of cardiovascular diseases and disorders, and for identifying agents therapeutic therefor
02/06/2003US20030026796 Method for treating a subject suffering from conditions associated with an extracellular zinc sphingomyelinase
02/06/2003US20030026793 Hypoxia inducing factors and uses thereof for inducing angiogenesis and improving muscular functions
02/06/2003US20030026780 Innate immunity mediated methods of treating pathological conditions
02/06/2003US20030026778 Chimeric cytokines and uses thereof
02/06/2003US20030026777 Detection and treatment of breast disease
02/06/2003CA2455360A1 Novel peptides of the respiratory syncytial virus (rsv) g protein and their use in a vaccine
02/06/2003CA2454824A1 Treatment of immune disorders and b cell disorders
02/06/2003CA2454784A1 Identification of specific tumour antigens by means of the selection of cdna libraries with sera and the use of said antigens in diagnostic imaging techniques
02/06/2003CA2454562A1 Method of improving cognitive function
02/06/2003CA2454515A1 Cancer diagnostics
02/06/2003CA2454469A1 Blood group antigen fusion polypeptides and methods of use thereof
02/06/2003CA2454342A1 Methods, compositions and kits relating to chitinases and chitinase-like molecules and inflammatory disease
02/06/2003CA2450073A1 Compositions and methods for modulating blood-brain barrier transport
02/05/2003EP1281971A1 Method and kit for quantifying beta-lactam penicillins
02/05/2003EP1281770A2 Human brain phosphodiesterase and screening method